RheumNow Week in Review – 16 September 2016 Save
RheumNow Week in Review – 16 September 2016-YouTube
Dr. Jack Cush reviews highlights in the news and journals from this past week at RheumNow.
- 40 die daily in US from narcotics. Rx opioid overdose & abuse has an estimated economic burden 78.5 billion in USA https://t.co/XW78zdYthn
- The new rituximab biosimilar CT-P10 shows comparable results to original rituximab (efficacy, pharmacodynamics, and immunogenicity/safety) https://t.co/hNjcxbF9Mu
- TNFi induced Psoriasis can be treated w/ TNFi D/C, another TNFi (48-85% recurrence) or Stelara. Good short review https://t.co/PAtJOOfFIV
- It's the engine that kills ya’, not the caboose. Dr Cush focuses on the toxic potential of disease activity https://t.co/tCcbiy3anV
- EMA/FDA grants orphan status to Nintedanib (a kinase inhib) for Scleroderma, largely based on it’s approval for ILD. The PSS trial is in progress https://t.co/cdo0kZ5ETx
- Mayo Scleroderma study -severe dysmotility is more in diffuse > limited dz; but Scleroderma esophagus in 1/3 of both https://t.co/WqqFLmTieq
- 180 pts with head & neck cancer treated w/ TNFi or DMARD- TNFi did not increase risk of cancer recurrence (HR 0.75) https://t.co/7tbhO4V0To
- CDC Flu vaccine rules 2016-17 - NO flumyst use, give injx flu vaccine before end October, Egg allergy observe 15 min https://t.co/yNLuFhL9UQ
- CDC Reports 31 Million Older Americans Don't Get Adequate Exercise
- New Shingles Vaccine (Shingrix) Effective for up to Four Years.
- CPAP Use Fails to Prevent CV Events in Sleep Apnea Patients
More ACR Coverage:
ADD THE FIRST COMMENT
Disclosures
Disclosures
The author has no conflicts of interest to disclose related to this subject

If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.